Human Amniotic Membrane Products for Patients with Diabetic Foot Ulcers. Do They Help? a Systematic Review and Meta-analysis

Overview

Journal J Foot Ankle Res

Publisher Wiley

Specialty Orthopedics

Date 2022 Sep 14

PMID 36104736

Authors

Yasmine Adel Mohammed

Hossam Khaled Farouk

Mohamed Ibrahim Gbreel

Abdelrahman Mahmoud Ali

Ali Ashraf Salah

Anas Zakarya Nourelden

Mohamed Mahmoud Abd-El Gawad

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic foot ulcer (DFU) is one of the most serious diabetic complications. DFU is an open wound that usually occurs in the foot sole due to poor blood glucose control, peripheral neuropathy, and poor circulation. The human amniotic allograft membrane is a biological wound dressing derived from the amniotic membrane. It contains amino acids, nutrients, cytokines, and growth factors that make the growth process easier.

Objective: To compare dehydrated human amnion and chorion allograft (DHACA) plus the standard of wound care (SOC) with the SOC alone.

Methods: We searched for randomized clinical trials (RCTs) on PubMed, Scopus, Cochrane, and Web of Science till April 2021 using relevant keywords. All search results were screened for eligibility. We extracted the data from the included trials and pooled them as mean difference (MD) or risk ratio (RR) with the 95% confidence interval (CI) using Review Manager software (ver. 5.4).

Results: The pooled effect estimate from 11 RCTs showed that DHACA was superior to SOC regarding the complete wound healing in both 6th and 12th week (RR = 3.78; 95% CI: [2.51, 5.70]; P < 0.00001) and (RR = 2.00; 95% CI: [1.67, 2.39], P < 0.00001 respectively). Also, the analysis favored the DHACA regarding the mean time to heal in the 12th-week (MD = -12.07, 95%CI: [-19.23, -4.91], P = 0.001). The wound size reduction was better with DHACA (MD = 1.18, 95%CI: [-0,10, 2.26], P = 0.03).

Conclusion: Using DHACA with SOC is safer and more effective than using SOC alone for DFU patients.

Citing Articles

A Randomized Controlled Clinical Trial Comparing the Use of High Purity Type-I Collagen-Based Skin Substitute vs. Dehydrated Human Amnion/Chorion Membrane in the Treatment of Diabetic Foot Ulcers.

Narayan N, Gowda S, Shivannaiah C Cureus. 2024; 16(12):e75182.

PMID: 39649230 PMC: 11621241. DOI: 10.7759/cureus.75182.

Application of Fetal Membranes and Natural Materials for Wound and Tissue Repair.

Rouzaire M, Blanchon L, Sapin V, Gallot D Int J Mol Sci. 2024; 25(22).

PMID: 39595963 PMC: 11594142. DOI: 10.3390/ijms252211893.

Clinical Evaluation of AMNIODERM+ Wound Dressing Containing Non-Viable Human Amniotic Membrane: Retrospective-Perspective Clinical Trial.

Schmiedova I, Slama P, Dembickaja A, Kozova B, Hyneckova V, Gogolkova S BioTech (Basel). 2024; 13(3).

PMID: 39311338 PMC: 11417787. DOI: 10.3390/biotech13030036.

Is Spontaneous Preterm Prelabor of Membrane Rupture Irreversible? A Review of Potentially Curative Approaches.

Danciu B, Otelea M, Marincas M, Nitescu M, Simionescu A Biomedicines. 2023; 11(7).

PMID: 37509539 PMC: 10377155. DOI: 10.3390/biomedicines11071900.

Diabetic Foot Ulcers: A Review.

Armstrong D, Tan T, Boulton A, Bus S JAMA. 2023; 330(1):62-75.

PMID: 37395769 PMC: 10723802. DOI: 10.1001/jama.2023.10578.

References

Lavery L, Armstrong D, Wunderlich R, Mohler M, Wendel C, Lipsky B . Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29(6):1288-93. DOI: 10.2337/dc05-2425. View

DiDomenico L, Orgill D, Galiano R, Serena T, Carter M, Kaufman J . Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial. Plast Reconstr Surg Glob Open. 2016; 4(10):e1095. PMC: 5096542. DOI: 10.1097/GOX.0000000000001095. View

Schmidt W . The amniotic fluid compartment: the fetal habitat. Adv Anat Embryol Cell Biol. 1992; 127:1-100. DOI: 10.1007/978-3-642-77300-6. View

Hingorani A, LaMuraglia G, Henke P, Meissner M, Loretz L, Zinszer K . The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016; 63(2 Suppl):3S-21S. DOI: 10.1016/j.jvs.2015.10.003. View

Driver V, Lavery L, Reyzelman A, Dutra T, Dove C, Kotsis S . A clinical trial of Integra Template for diabetic foot ulcer treatment. Wound Repair Regen. 2015; 23(6):891-900. DOI: 10.1111/wrr.12357. View

Reyzelman A, Crews R, Moore J, Moore L, Mukker J, Offutt S . Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J. 2009; 6(3):196-208. PMC: 7951349. DOI: 10.1111/j.1742-481X.2009.00585.x. View

Lavery L, Peters E, Williams J, Murdoch D, Hudson A, Lavery D . Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2007; 31(1):154-6. DOI: 10.2337/dc07-1302. View

Serena T, Yaakov R, Moore S, Cole W, Coe S, Snyder R . A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers. J Comp Eff Res. 2019; 9(1):23-34. DOI: 10.2217/cer-2019-0142. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

10.

Farhadihosseinabadi B, Farahani M, Tayebi T, Jafari A, Biniazan F, Modaresifar K . Amniotic membrane and its epithelial and mesenchymal stem cells as an appropriate source for skin tissue engineering and regenerative medicine. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):431-440. DOI: 10.1080/21691401.2018.1458730. View

11.

Insausti C, Blanquer M, Bleda P, Iniesta P, Majado M, Castellanos G . The amniotic membrane as a source of stem cells. Histol Histopathol. 2009; 25(1):91-8. DOI: 10.14670/HH-25.91. View

12.

Burgos H . Angiogenic and growth factors in human amnio-chorion and placenta. Eur J Clin Invest. 1983; 13(4):289-96. DOI: 10.1111/j.1365-2362.1983.tb00103.x. View

13.

Thompson P, Hanson D, Langemo D, Anderson J . Comparing Human Amniotic Allograft and Standard Wound Care When Using Total Contact Casting in the Treatment of Patients with Diabetic Foot Ulcers. Adv Skin Wound Care. 2019; 32(6):272-277. DOI: 10.1097/01.ASW.0000557831.78645.85. View

14.

Woods T, Tesfay F, Speck P, Kaambwa B . Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review. PLoS One. 2020; 15(4):e0232395. PMC: 7192475. DOI: 10.1371/journal.pone.0232395. View

15.

Veves A, Falanga V, Armstrong D, Sabolinski M . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001; 24(2):290-5. DOI: 10.2337/diacare.24.2.290. View

16.

DiDomenico L, Orgill D, Galiano R, Serena T, Carter M, Kaufman J . Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients. Int Wound J. 2018; 15(6):950-957. PMC: 7949511. DOI: 10.1111/iwj.12954. View

17.

Zelen C, Gould L, Serena T, Carter M, Keller J, Li W . A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity.... Int Wound J. 2014; 12(6):724-32. PMC: 7950807. DOI: 10.1111/iwj.12395. View

18.

Tettelbach W, Cazzell S, Reyzelman A, Sigal F, Caporusso J, Agnew P . A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int Wound J. 2018; 16(1):19-29. PMC: 7379535. DOI: 10.1111/iwj.12976. View

19.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

20.

Marston W, Hanft J, Norwood P, Pollak R . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003; 26(6):1701-5. DOI: 10.2337/diacare.26.6.1701. View